About the Biological evaluation Session
A product or substance's safety and effectiveness are evaluated biologically by examining how it affects living things. It includes a broad range of methods and procedures, from figuring out how hazardous a material is to figuring out how successful it is as a medication or dietary supplement. A product or substance's potential advantages and hazards, as well as any negative impacts it might have on the environment or people's health, can all be determined through biological evaluation. The identification of the target organism and the characteristics that must be watched over to assess safety and efficacy is the first step in the biological evaluation process. This involves identifying endpoints that might shed light on the impacts of the study's subject (product or substance), such as mortality, growth, or reproductive success. The next step is to choose the best experimental approach once the endpoints have been established. This might entail testing in vivo, in vitro, or a mix of the two. In vitro tests are often carried out in lab settings where cell cultures, organs, or other biological material may be exposed to different amounts of the drug being researched. The impact of the drug on numerous biological systems may then be measured by researchers. On the other hand, in vivo testing takes place on live things like animals or people.
Topics Covered in Biological evaluation
In vitro bioactivity assays
Antimicrobial and antifungal testing
Antioxidant capacity evaluation
Cytotoxicity and safety screening
Dose–response and statistical analysis
Standardisation of bioassay protocols
Featured Speakers — Biological evaluation 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Biological evaluation Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at GPB 2027
Why Attend the Biological evaluation Conference 2027
Earn CPD Credit
Sessions are CPD-accredited — earn 1 CPD credit for each hour of attendance.
Present Your Research
Oral and poster slots for original Biological evaluation work, reviewed by the scientific committee.
Network Globally
Meet plant scientists, breeders, biotechnologists and crop researchers from around the world across three days.
Featured in the Abstract Book
Accepted abstracts are collected in the conference abstract book, published for every edition.
Learn from Keynotes
Plenary lectures from leading voices shaping Biological evaluation research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join GPB 2027 for the Biological evaluation track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Biological evaluation Conference 2027 — FAQs
What is the Biological evaluation track at GPB 2027?
The Biological evaluation track is a dedicated stream within GPB 2027 covering the latest research, clinical innovation, and best practice in Biological evaluation. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Biological evaluation sessions?
Plant scientists, breeders, biotechnologists, agronomists, doctoral students, and research leaders with an interest in Biological evaluation are all welcome — whether presenting or attending.
Can I present my research in the Biological evaluation track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Biological evaluation sessions?
Yes. GPB 2027 is a hybrid conference — attend the Biological evaluation track in person in Singapore or join live online, with on-demand access afterward.
Join the GPB 2027 delegation
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
